Account

Industry resources and insights

Sort by year
  • All time
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020 and older
Poster
02.03.2026
Private versus public access: Exploring how obesit...

Obesity medicines (OMs), including GLP-1 receptor agonists such as semaglutide (Wegovy®) and tirzep...

Read more
Articles
25.02.2026
Orphan Drug Designation: A Head Start, Not a Fre...

Manufacturers looking to optimise access for their orphan drugs need to navigate a complex environme...

Read more
Insider Insights
16.02.2026
TrumpRx: Structural Shift or Symbolic Gesture? 

TrumpRx, the most recent direct-to-consumer platform aimed at cutting drug prices for Amer...

Read more
Case Studies
09.02.2026
Outcomes-Based Agreements Aren’t a Silver ...

The price of innovative, next generation therapies has outpaced payer budgets for som...

Read more
Articles
28.01.2026
If You’re a Market Access Lead in 2026: How to N...

In 2026, U.S. policy shifts will link domestic US prices to internatio...

Read more
Webinar
26.01.2026
Top Market Access Trends for 2026

As Market Access continues to evolve amid policy reform, pricing pressure, and increasing evidence e...

Read more
Load more
Browse by topic
Content type
  • All
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
Subscribe
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch